The molecular basis of α-thalassemia.

The globin gene disorders including the thalassemias are among the most common human genetic diseases with more than 300,000 severely affected individuals born throughout the world every year. Because of the easy accessibility of purified, highly specialized, mature erythroid cells from peripheral b...

Full description

Bibliographic Details
Main Author: Higgs, DR
Format: Journal article
Language:English
Published: 2013
_version_ 1826258995150585856
author Higgs, DR
author_facet Higgs, DR
author_sort Higgs, DR
collection OXFORD
description The globin gene disorders including the thalassemias are among the most common human genetic diseases with more than 300,000 severely affected individuals born throughout the world every year. Because of the easy accessibility of purified, highly specialized, mature erythroid cells from peripheral blood, the hemoglobinopathies were among the first tractable human molecular diseases. From the 1970s onward, the analysis of the large repertoire of mutations underlying these conditions has elucidated many of the principles by which mutations occur and cause human genetic diseases. This work will summarize our current knowledge of the α-thalassemias, illustrating how detailed analysis of this group of diseases has contributed to our understanding of the general molecular mechanisms underlying many orphan and common diseases.
first_indexed 2024-03-06T18:42:52Z
format Journal article
id oxford-uuid:0d7e8798-55b9-4b13-a0fe-abbf5bfe00a8
institution University of Oxford
language English
last_indexed 2024-03-06T18:42:52Z
publishDate 2013
record_format dspace
spelling oxford-uuid:0d7e8798-55b9-4b13-a0fe-abbf5bfe00a82022-03-26T09:40:50ZThe molecular basis of α-thalassemia.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:0d7e8798-55b9-4b13-a0fe-abbf5bfe00a8EnglishSymplectic Elements at Oxford2013Higgs, DRThe globin gene disorders including the thalassemias are among the most common human genetic diseases with more than 300,000 severely affected individuals born throughout the world every year. Because of the easy accessibility of purified, highly specialized, mature erythroid cells from peripheral blood, the hemoglobinopathies were among the first tractable human molecular diseases. From the 1970s onward, the analysis of the large repertoire of mutations underlying these conditions has elucidated many of the principles by which mutations occur and cause human genetic diseases. This work will summarize our current knowledge of the α-thalassemias, illustrating how detailed analysis of this group of diseases has contributed to our understanding of the general molecular mechanisms underlying many orphan and common diseases.
spellingShingle Higgs, DR
The molecular basis of α-thalassemia.
title The molecular basis of α-thalassemia.
title_full The molecular basis of α-thalassemia.
title_fullStr The molecular basis of α-thalassemia.
title_full_unstemmed The molecular basis of α-thalassemia.
title_short The molecular basis of α-thalassemia.
title_sort molecular basis of α thalassemia
work_keys_str_mv AT higgsdr themolecularbasisofathalassemia
AT higgsdr molecularbasisofathalassemia